Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Vaccine|June 15, 2025
Low and inequitable influenza and COVID-19 vaccination coverage among pregnant women in Norway: Nationwide population-based cohort studyBo T Hansen, Jesper Dahl, Margrethe Greve-Isdahl, et al.
BMC Public Health|May 29, 2024
Social contact patterns during the early COVID-19 pandemic in Norway: insights from a panel study, April to September 2020Lamprini Veneti, Bjarne Robberstad, Anneke Steens, et al.
The Lancet. Respiratory Medicine|April 1, 2017
Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre studyCamelia Savulescu, Pavla Krizova, Agnes Lepoutre, et al.
Vaccine|May 31, 2022
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre studyCamelia Savulescu, Pavla Krizova, Palle Valentiner-Branth, et al.
Thorax|October 26, 2018
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccinationGermaine Hanquet, Pavla Krizova, Palle Valentiner-Branth, et al.
Emerging Infectious Diseases|December 21, 2021
Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, EuropeGermaine Hanquet, Pavla Krizova, Tina Dalby, et al.
Microorganisms|April 30, 2021
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE ProjectMaria Garcia Quesada, Yangyupei Yang, Julia C Bennett, et al.
The Journal of Infection|January 26, 2025
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE projectYangyupei Yang, Maria Deloria Knoll, Carly Herbert, et al.
The Lancet. Infectious Diseases|December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysisJulia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
Microorganisms|April 3, 2021
Changes in Invasive Pneumococcal Disease Caused by <i>Streptococcus pneumoniae</i> Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE ProjectJulia C Bennett, Marissa K Hetrich, Maria Garcia Quesada, et al.
Pageof 2